CA2148898A1 - Proteine p54 activee par le stress - Google Patents
Proteine p54 activee par le stressInfo
- Publication number
- CA2148898A1 CA2148898A1 CA 2148898 CA2148898A CA2148898A1 CA 2148898 A1 CA2148898 A1 CA 2148898A1 CA 2148898 CA2148898 CA 2148898 CA 2148898 A CA2148898 A CA 2148898A CA 2148898 A1 CA2148898 A1 CA 2148898A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- seq
- leu
- ser
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24001494A | 1994-05-09 | 1994-05-09 | |
US08/240,014 | 1994-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2148898A1 true CA2148898A1 (fr) | 1995-11-10 |
Family
ID=22904740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2148898 Abandoned CA2148898A1 (fr) | 1994-05-09 | 1995-05-08 | Proteine p54 activee par le stress |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2148898A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2788531A1 (fr) * | 1999-01-20 | 2000-07-21 | Aventis Pharma Sa | Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations |
WO2000043524A1 (fr) * | 1999-01-20 | 2000-07-27 | Aventis Pharma S.A. | Polypeptides derives de jnk3 |
WO2002012338A2 (fr) * | 2000-08-03 | 2002-02-14 | Grünenthal GmbH | Procede de criblage |
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
-
1995
- 1995-05-08 CA CA 2148898 patent/CA2148898A1/fr not_active Abandoned
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
US7264942B2 (en) | 1998-05-14 | 2007-09-04 | Ya Fang Liu | Method for identifying JNK and MLK inhibitors for treatment of neurological conditions |
US7452686B2 (en) | 1998-05-14 | 2008-11-18 | Ya Fang Liu | JNK inhibitors for the treatment of neurological disorders |
FR2788531A1 (fr) * | 1999-01-20 | 2000-07-21 | Aventis Pharma Sa | Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations |
WO2000043524A1 (fr) * | 1999-01-20 | 2000-07-27 | Aventis Pharma S.A. | Polypeptides derives de jnk3 |
US6649388B2 (en) | 1999-01-20 | 2003-11-18 | Aventis Pharma S.A. | Polypeptides derived from JNK3 |
WO2002012338A2 (fr) * | 2000-08-03 | 2002-02-14 | Grünenthal GmbH | Procede de criblage |
WO2002012338A3 (fr) * | 2000-08-03 | 2002-12-19 | Gruenenthal Gmbh | Procede de criblage |
EP1469316A1 (fr) * | 2000-08-03 | 2004-10-20 | Grünenthal GmbH | Procédé de criblage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kyriakis et al. | The stress-activated protein kinase subfamily of c-Jun kinases | |
Rahman et al. | Gαq and Gβγ regulate PAR-1 signaling of thrombin-induced NF-κB activation and ICAM-1 transcription in endothelial cells | |
Laine et al. | The protooncogene TCL1 is an Akt kinase coactivator | |
Liu et al. | Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. | |
Inagaki et al. | Cardioprotection by ε-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an ε-protein kinase C-activating peptide | |
Kirken et al. | Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells | |
US8658594B2 (en) | Peptide inhibitors of protein kinase C | |
Bian et al. | Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins | |
Kaufmann et al. | Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor-and cAMP-mediated signaling | |
Tharaux et al. | Rho kinase promotes alloimmune responses by regulating the proliferation and structure of T cells | |
Øie et al. | Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats | |
CA2126523A1 (fr) | Kinases jak et regulation de la transduction du signal des cytokines | |
Ohbayashi et al. | LIF-and IL-6-induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation | |
AU752617B2 (en) | A novel human checkpoint kinase, hCDS1, compositions and methods | |
US7741290B2 (en) | Method of preventing progression of hypertension-induced heart failure with PKC peptides | |
US5621075A (en) | Insulin receptor substrate | |
CZ298866B6 (cs) | Izolovaný polypeptid, izolovaná sekvence DNA, farmaceutická kompozice a použití izolovaného polypeptidu pro výrobu farmaceutického prostredku | |
Kessler et al. | Diversification of cardiac insulin signaling involves the p85α/β subunits of phosphatidylinositol 3-kinase | |
US6326181B1 (en) | Cell volume-regulated human kinase h-sgk | |
Bryson et al. | The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension | |
CA2411396A1 (fr) | Inhibiteurs de la hmg coa reductase pour favoriser l'angiogenese | |
US7368113B2 (en) | Hormonally up-regulated, neu-tumor-associated kinase | |
JP2002528390A (ja) | 細胞の生存を増強するためのakt組成物 | |
US5830699A (en) | SOK-1 and methods of use | |
Flores-Morales et al. | In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |